原著 |
|
|
|
|
2型糖尿病患者合并代谢综合征增加Framingham心血管危险评分 |
姚美芳1,2, 孙雪1, 韩珏1, 屠伊娜1, 何洁1, 赵一鸣1, 楼寒钰1, 庞晓红1, 曾文衡1, 张松照3, 单鹏飞1 |
1. 浙江大学医学院附属第二医院内分泌科, 浙江 杭州 310009;
2. 浙江医院健康管理中心, 浙江 杭州 310013;
3. 浙江大学医学院附属第二医院检验科, 浙江 杭州 310009 |
|
Metabolic syndrome increases Framingham risk score of patients with type 2 diabetes mellitus |
YAO Meifang1,2, SUN Xue1, HAN Jue1, TU Yina1, HE Jie1, ZHAO Yiming1, LOU Hanyu1, PANG Xiaohong1, ZENG Wenheng1, ZHANG Songzhao3, SHAN Pengfei1 |
1. Department of Endocrinology and Metabolism, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China;
2. Health Management Center, Zhejiang Hospital, Hangzhou 310013, China;
3. Department of Clinical Laboratory, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China |
引用本文:
姚美芳 等. 2型糖尿病患者合并代谢综合征增加Framingham心血管危险评分[J]. 浙江大学学报(医学版), 2016, 45(3): 268-274.
YAO Meifang, SUN Xue, HAN Jue, TU Yina, HE Jie, ZHAO Yiming, LOU Hanyu, PANG Xiaohong, ZENG Wenheng, ZHANG Songzhao, SHAN Pengfei. Metabolic syndrome increases Framingham risk score of patients with type 2 diabetes mellitus. Journal of ZheJiang University(Medical Science), 2016, 45(3): 268-274.
链接本文:
http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2016.05.08
或
http://www.zjujournals.com/xueshu/med/CN/Y2016/V45/I3/268
|
[1] |
KISHORE P, KIM S H, CRANDALL J P. Glycemic control and cardiovascular disease: what's a doctor to do?[J]. Curr Diab Rep, 2012, 12(3):255-264.
|
[2] |
李光伟. 关注血糖达标与低血糖风险之间的平衡——谈糖尿病合并心血管疾病的降血糖治疗[J].中华内分泌代谢杂志, 2012,28(1):1-3. LI Guangwei. Pay more attention to the balance between "treat to target" and risk of hypoglycemia comment on the strategy of glycemic control in diabetic patients with cardiovascular disease[J]. Chinese Journal of Endocrinology and Metabolism, 2012, 28(1):1-3. (in Chinese)
|
[3] |
YIN J H, SONG Z Y, SHAN P F, et al. Age-and gender-specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in Hangzhou, China[J]. Clin Endocrinol (Oxf), 2012, 76(6): 802-809.
|
[4] |
BODEN-ALBALA B,SACCO R L,LEE H S,et al. Metabolic syndrome and ischemic stroke risk Northern Manhattan Study[J]. Stroke, 2008,39(1): 30-35.
|
[5] |
RHEE S Y, PARK S Y, HWANG J K, et al. Metabolic syndrome as an indicator of high cardiovascular risk in patients with diabetes: analyses based on Korea National Health and Nutrition Examination Survey (KNHANES) 2008[J]. Diabetol Metab Syndr, 2014, 6(1):98.
|
[6] |
BAE J C, CHO N H, SUH S, et al. Cardiovascular disease incidence, mortality and case fatality related to diabetes and metabolic syndrome: a community-based prospective study(Ansung-Ansan cohort 2001-12)[J]. Diabetes, 2014, 7(6):791-799.
|
[7] |
MEHTA N N, KRISHNAMOORTHY P, MARTIN S S, et al. Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus[J]. Am J Cardiol, 2011, 107(3): 406-411.
|
[8] |
SCOTT R, DONOGHOE M, WATTS G F, et al. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial[J]. Cardiovasc Diabetol, 2011, 10:102.
|
[9] |
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report[J]. Circulation, 2002, 106(25):3143-3421.
|
[10] |
GRUNDY S M, CLEEMAN J I, DANIELS S R, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement[J]. Circulation, 2005, 112(17): 2735-2752.
|
[11] |
WHITING D R, GUARIGUATA L, WEIL C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030[J]. Diabetes Res Clin Pract, 2011, 94(3): 311-321.
|
[12] |
GUARIGUATA L, WHITING D R, HAMBLETON I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035[J]. Diabetes Res Clin Pract, 2014, 103(2):137-149.
|
[13] |
XU Y,WANG L,HE J,et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA,2013, 310(9): 948-959.
|
[14] |
Action to Control Cardiovascular Risk in Diabetes Study Group, GERSTEIN H C, MILLER M E, et al. Effects of intensive glucose lowering in type 2 diabetes[J]. N Engl J Med, 2008, 358(24): 2545-2559.
|
[15] |
KIM C J, KANG H S, SCHLENK E A, et al. Assessment of cardiovascular risk in adults with type 2 diabetes and metabolic syndrome: Framingham versus UKPDS equations[J]. Diabetes Educ, 2015, 41(2): 203-213.
|
[16] |
SALEEM T, MOHAMMAD K H, ABDEL-FATTAH M M, et al.Association of glycosylated haemoglobin level and diabetes mellitus duration with the severity of coronary artery disease[J]. Diab Vasc Dis Res, 2008, 5(3):184-189.
|
[17] |
GAO Y, LU B, SUN M L, et al.Comparison of atherosclerotic plaque by computed tomography angiography in patients with and without diabetes mellitus and with known or suspected coronary artery disease.[J]. Am J Cardiol, 2011,108(6): 809-813.
|
[18] |
FRANZINI L, ARDIGÒ D, CAVALOT F et al. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology[J]. Nutr Metab Cardiovasc Dis, 2013, 23(3):235-241.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|